{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:46:21Z","timestamp":1743266781040},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":266,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 62-year-old woman with a history of abdominal pain presented with multiple hepatic lesions and dilatation of portal, splenic and superior mesenteric veins on the magnetic resonance imaging referred for a 99mTc-octreotide scan. Accordingly, similar octreotide-avid lesions were found as well as an uptake in the epigastric region conforming to the anatomy of the portocaval venous system, compatible with a tumor thrombosis. Then, the patient underwent two cycles of therapy with 177Lu-DOTA-TATE, on that the same appearance was observed. The uptake in the tumor thrombus remained somewhat unchanged, but clinically, a significant improvement of the intractable ascites was achieved.<\/jats:p>","DOI":"10.4103\/wjnm.wjnm_35_21","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:58:44Z","timestamp":1629467924000},"page":"324-326","source":"Crossref","is-referenced-by-count":2,"title":["Somatostatin-receptor avidity of pancreatic neuroendocrine tumor thrombus in porto-caval venous systems on 99mTc-Octreotide and posttherapeutic 177Lu-DOTA-TATE scans"],"prefix":"10.1055","volume":"20","author":[{"given":"Mahasti","family":"Amoui","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhane","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging, Farshchian Heart Center, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Qutbi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa Neshandar","family":"Asli","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,3,24]]},"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/wjnm.wjnm_35_21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:57:49Z","timestamp":1649174269000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/wjnm.wjnm_35_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":0,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.4103\/wjnm.wjnm_35_21","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}